November 27, 2014 5:08 PM ET

Capital Markets

Company Overview of PureTech Ventures

Company Overview

Puretech Ventures is a venture capital and private equity firm specializing in pre-seed, seed, early stage, and bridge financing. The firm seeks to invest in life sciences companies with a focus on novel therapeutics, medical devices, pharmaceuticals, immunology, metabolism, consumer and digital, neuroscience, drug delivery, and research and platform technologies. Puretech Ventures was founded in 2001 and is based in Boston, Massachusetts.

500 Boylston Street

Suite 1600

Boston, MA 02116

United States

Founded in 2001

Phone:

617-482-2333

Fax:

617-482-3337

Key Executives for PureTech Ventures

Co-Founder
Age: 75
Co-Founder
Age: 66
Co-Founder and Senior Advisor
Age: 66
Manager of Finance and Operations
Compensation as of Fiscal Year 2014.

PureTech Ventures Key Developments

PureTech Announces Closing of $55 Million Growth Stage Investment Round; Announces Appointment of Three New Senior Partners

PureTech announced the closing of a $55 million growth stage investment round, with participation from Invesco Perpetual, a $120 billion group of funds. The funding will be used to drive its existing pipeline forward and to advance new healthcare related products and technologies. In conjunction with the funding round, the company announced the appointment of three new senior partners: Dr. H Robert Horvitz, Nobel Laureate, David H. Koch Professor at MIT, and Investigator, Howard Hughes Medical Institute; Mr. Joi Ito, director of the MIT Media Lab and board member of Sony, the MacArthur Foundation, The New York Times, the Knight Foundation and Mozilla; and Dr. Raju Kucherlapati, Paul C. Cabot Professor in the Harvard Medical School Department of Genetics, co-founder of Millennium Pharmaceuticals & Abgenix, and Member of President Obama's Commission for the Study of Bioethical Issues. The new senior partners will join its existing senior partners and board members, Dr. Robert Langer, PureTech Co-founder & David H. Koch Institute Professor at MIT, Dr. Ben Shapiro, PureTech Chairman, former EVP of Worldwide Basic & External Research at Merck, Dr. John LaMattina, the company’s senior partner and former president of R & D at Pfizer Global Research and Development, and Daphne Zohar, the company’s Founder & CEO, recognized as a healthcare innovator and leader by the Boston Globe, MIT's Technology Review, Fierce Biotech and BioWorld.

PureTech Presents at Life Sciences Summit 2013, Nov-21-2013 02:15 PM

PureTech Presents at Life Sciences Summit 2013, Nov-21-2013 02:15 PM. Venue: Convene - Midtown East, 730 Third Avenue (Between East 45th and 46th Streets), 17th Floor, New York, NY 10017, United States. Speakers: Eric Elenko, Partner.

PureTech Ventures Presents at BioPharm America 2013, Sep-17-2013 through Sep-19-2013

PureTech Ventures Presents at BioPharm America 2013, Sep-17-2013 through Sep-19-2013. Venue: Westin Boston Waterfront Hotel, Boston, Massachusetts, United States. Presentation Date & Speakers: Sep-17-2013, Daphne Zohar, Founder, Managing Partner, and Director. Sep-18-2013, Daphne Zohar, Founder, Managing Partner, and Director.

Similar Private Companies By Industry

Company Name Region
Cliffwater LLC United States
Evolution Markets Inc. United States
Giuliani Capital Advisors LLC United States
Aldabra 3 Acquisition Corp. United States
Hospitality Funding LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 20, 2014
--
Private Placement
May 16, 2014
Gelesis, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PureTech Ventures, please visit www.puretechventures.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.